Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines... see more

CSE:MDMA - Post Discussion

View:
Post by inviolablspirit on Nov 21, 2024 6:06pm

News Releases

I'm going to guess that we may not get the agreement signed and announced until after the financials are released.   And we may get other news releases from now until then.   Or we get the agreement signed before the financials and then we see other news releases after the financials.  Either way I predict we have news release(s) coming before financials are released in December.  

I'm also interested in news releases regarding European countries.  Last time I emailed Nick he said "the regulations for Europe are complex, but not impossible".  And if there's anyone that understands regulations and can get a deal done, it's Nick.  So I think anything out of Europe will take more time then anything we see signed in North America.   When Nick is back in Europe that's when we may see deals being signed.  Anything I see signed from Europe before that, I'll view as a bonus.  

Also depending on what deals are being signed, some deals may require the other party's desire to see the audited Y/E financial statements first before going forward.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities